| Business Summary | | The
Cooper
Companies,
Inc.,
through
its
principal
subsidiaries,
develops,
manufactures
and
markets
healthcare
products.
CooperVision
(CVI)
markets
a
range
of
contact
lenses
to
correct
visual
defects,
specializing
in
toric
lenses
that
correct
astigmatism.
Its
leading
products
are
disposable-planned
replacement
toric
and
spherical
lenses.
CVI
also
markets
conventional
toric
and
spherical
lenses
and
lenses
for
patients
with
more
complex
vision
disorders.
CooperSurgical
(CSI)
markets
diagnostic
products,
surgical
instruments
and
accessories
to
the
women's
healthcare
market. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | The
Cooper
Companies
is
a
specialty
healthcare
company.
Each
of
its
business
units
serves
attractive
niche
markets
in
the
medical
device
market
with
high
quality
products
and
services.
For
the
six
months
ended
4/30/01,
revenues
rose
15%
to
$104.9
million.
Net
income
before
accounting
change
rose
30%
to
$15
million.
Revenues
reflect
increased
CVI
volumes
and
CSI
existing
product
sales.
Earnings
also
reflect
continuing
cost
reduction
projects. Recent Earnings Announcement For
the
3
months
ended
07/31/2001,
revenues
were
59,961;
after
tax
earnings
were
10,361. (Preliminary; reported in thousands of dollars.) | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Allan Rubenstein, M.D., 56 Chairman
of Directors | -- | -- | A. Thomas Bender, 62 Pres
and CEO | $678K | $1.4M | Nicholas Pichotta, 56 Pres
and CEO of CooperSurgical, Inc. | 285K | 154K | Robert Weiss, 54 Exec.
VP, CFO, Treasurer | 458K | 417K | Stephen Whiteford, 60 VP
and Corp. Controller | -- | -- | Dollar
amounts are as of 31-Oct-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|